• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Conexeu Sciences Inc. - Common Stock (NQ:CNXU)

9.250 -1.550 (-14.35%)
Streaming Delayed Price Updated: 2:43 PM EDT, Jul 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 304,841
Open 11.11
Bid (Size) 9.200 (100)
Ask (Size) 9.450 (100)
Prev. Close 10.80
Today's Range 9.250 - 11.51
52wk Range 9.600 - 18.79
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
A Nasdaq-Listed Regenerative Tissue Company Just Opened a Lab: The Next Step in Scaling a Platform Built for a NEW Aesthetics Opportunity
July 01, 2026
From Biotech Insider
Via GlobeNewswire
News headline image
The Aesthetics Giants Just Confirmed “Ozempic Face” Is Real — and a Newly Public Regenerative Player Wants to Compete for It
June 25, 2026
From Biotech Insider
Via GlobeNewswire

Performance

YTD
-29.2%
-29.2%
1 Month
-39.4%
-39.4%
3 Month
-29.2%
-29.2%
6 Month
-29.2%
-29.2%
1 Year
-29.2%
-29.2%

More News

Read More
News headline image
Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself
June 18, 2026
From Biotech Insider
Via GlobeNewswire
News headline image
The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It
June 16, 2026
From World Street Intelligence
Via GlobeNewswire
News headline image
A Fresh FDA Catalyst Is Putting Regenerative Wound Care in Focus
June 09, 2026
From Equity Insider
Via GlobeNewswire
News headline image
Before the IPO: 4 Companies That Rewarded Investors Who Got In Early ↗
June 04, 2026
Via MarketBeat
Topics Initial Public Offering
News headline image
After Fifty Years of Implants, a Newly Public Biotech Is Trying to Rebuild the Breast Instead
May 27, 2026
From Biotech Insider
Via GlobeNewswire
News headline image
The Newest Name on Nasdaq Wants to Help the Body Rebuild Itself
May 22, 2026
From Energy Metal News
Via GlobeNewswire
News headline image
A Reno Biotech Just Rang the Nasdaq Bell — Here’s Why the Whole Regenerative-Medicine Tape Is Worth Watching
May 22, 2026
From World Street Intelligence
Via GlobeNewswire
News headline image
Conexeu Sciences Commences Trading on Nasdaq Under Ticker Symbol "CNXU"
May 21, 2026
Via Newsfile

Frequently Asked Questions

Is Conexeu Sciences Inc. - Common Stock publicly traded?
Yes, Conexeu Sciences Inc. - Common Stock is publicly traded.
What exchange does Conexeu Sciences Inc. - Common Stock trade on?
Conexeu Sciences Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Conexeu Sciences Inc. - Common Stock?
The ticker symbol for Conexeu Sciences Inc. - Common Stock is CNXU on the Nasdaq Stock Market
What is the current price of Conexeu Sciences Inc. - Common Stock?
The current price of Conexeu Sciences Inc. - Common Stock is 9.250
When was Conexeu Sciences Inc. - Common Stock last traded?
The last trade of Conexeu Sciences Inc. - Common Stock was at 07/07/26 02:43 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap